Form 4 for TXG 10x Genomics, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0001610717-26-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-02-27 | 2026-02-25 | TXG | Teichmann Sarah A. | Dir | S - Sale | $19.41 | -7,579 | 26.8K | -22% | -$147.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-25 | S | D | 7,579 | $19.41 | 26,780 | D | — | — |